Sonenberg, N., & Hinnebusch, A. G. (2009). Regulation of translation initiation in eukaryotes: Mechanisms and biological targets. Cell, 136(4), 731–745. https://doi.org/10.1016/j.cell.2009.01.042

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ben-Shem, A., Garreau de Loubresse, N., Melnikov, S., Jenner, L., Yusupova, G., & Yusupov, M. (2011). The structure of the eukaryotic ribosome at 3.0 Å resolution. Science, 334(6062), 1524–1529. https://doi.org/10.1126/science.1212642

Kressler, D., Hurt, E., & Baßler, J. (2017). A puzzle of life: Crafting ribosomal subunits. Trends in Biochemical Sciences, 42(8), 640–654. https://doi.org/10.1016/j.tibs.2017.05.005

Article  CAS  PubMed  Google Scholar 

Liljas, A. and Ehrenberg, M. 2013. Structural aspects of protein synthesis. 2nd edition. World Scientific, Singapore. https://doi.org/10.1142/7793

Wolff, S., Weissman, J. S., & Dillin, A. (2014). Differential scales of protein quality control. Cell, 157(1), 52–64. https://doi.org/10.1016/j.cell.2014.03.007

Article  CAS  PubMed  Google Scholar 

Jaafar, M., Paraqindes, H., Gabut, M., Diaz, J.-J., Marcel, V., & Durand, S. (2021). 2′O-ribose methylation of ribosomal RNAs: Natural diversity in living organisms, biological processes, and diseases. Cells, 10(8), 1948. https://doi.org/10.3390/cells10081948

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhat, M., Robichaud, N., Hulea, L., Sonenberg, N., Pelletier, J., & Topisirovic, I. (2015). Targeting the translation machinery in cancer. Nature Reviews Drug Discovery, 14(4), 261–278. https://doi.org/10.1038/nrd4505

Article  CAS  PubMed  Google Scholar 

Robichaud, N., Sonenberg, N., Ruggero, D., & Schneider, R. J. (2019). Translational control in cancer. Cold Spring Harbor Perspectives in Biology, 11(7). https://doi.org/10.1101/cshperspect.a032896

Article  CAS  PubMed  PubMed Central  Google Scholar 

Massad, L. S., Mutch, D. G., Kao, M. S., Powell, C. B., & Collins, J. L. (1991). Inhibition of protein synthesis enhances the lytic effects of tumor necrosis factor α and interferon γ in cell lines derived from gynecological malignancies. Cancer Immunology, Immunotherapy : CII, 33(3), 183. https://doi.org/10.1007/BF01756140

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lang, T., Daxenbichler, G., & Marth, C. (1994). Effects of cytostatic agents on the expression of epidermal growth factor receptor in ovarian cancer cells. Anticancer research, 14(5A), 1871–1874.

CAS  PubMed  Google Scholar 

Schubert, M., Mettler, L., Deenadayal Tolani, A., & Alkatout, I. (2023). Fertility preservation in endometrial cancer—Treatment and molecular aspects. Medicina, 59(2), 221. https://doi.org/10.3390/medicina59020221

Article  PubMed  PubMed Central  Google Scholar 

Berek, J. S., Matias‐Guiu, X., Creutzberg, C., Fotopoulou, C., Gaffney, D., Kehoe, S., … Concin, N. (2023). FIGO staging of endometrial cancer: 2023. International Journal of Gynecology & Obstetrics, 162(2), 383–394. https://doi.org/10.1002/ijgo.14923

Dörk, T., Hillemanns, P., Tempfer, C., Breu, J., & Fleisch, M. C. (2020). Genetic susceptibility to endometrial cancer: Risk factors and clinical management. Cancers, 12(9), 2407. https://doi.org/10.3390/cancers12092407

Article  CAS  PubMed  PubMed Central  Google Scholar 

Viswanathan, A. N., Feskanich, D., De Vivo, I., Hunter, D. J., Barbieri, R. L., Rosner, B., … Hankinson, S. E. (2005). Smoking and the risk of endometrial cancer: Results from the Nurses’ Health Study. International Journal of Cancer, 114(6), 996–1001. https://doi.org/10.1002/ijc.20821

Chu, K.-T., Song, Y., & Zhou, J.-H. (2015). No effect of energy intake overall on risk of endometrial cancers: A meta-analysis. Asian Pacific Journal of Cancer Prevention, 15(23), 10293–10298. https://doi.org/10.7314/APJCP.2014.15.23.10293

Article  Google Scholar 

Verbakel, J. Y., Heremans, R., Wynants, L., Epstein, E., De Cock, B., Pascual, M. A., … Van den Bosch, T. (2022). Risk assessment for endometrial cancer in women with abnormal vaginal bleeding: Results from the prospective IETA‐1 cohort study. International Journal of Gynecology & Obstetrics, 159(1), 103–110. https://doi.org/10.1002/ijgo.14097

Zhao, M., Zhang, M.-J., He, L.-J., Zuo, C.-M., Ding, S.-R., Golden, A. R., & Cai, L. (2023). Health-related quality of life with cervical cancer and precancer: A cross-sectional study in Yunnan Province, China. Clinical and Experimental Obstetrics & Gynecology, 50(8), 161. https://doi.org/10.31083/j.ceog5008161

Wang, J., & Chen, L. (2019). The role of miRNAs in the invasion and metastasis of cervical cancer. Bioscience Reports, 39(3). https://doi.org/10.1042/BSR20181377

Xing, B., Guo, J., Sheng, Y., Wu, G., & Zhao, Y. (2021). human papillomavirus-negative cervical cancer: A comprehensive review. Frontiers in Oncology, 10. https://doi.org/10.3389/fonc.2020.606335

Smith, J. S., Lindsay, L., Hoots, B., Keys, J., Franceschi, S., Winer, R., & Clifford, G. M. (2007). Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. International Journal of Cancer, 121(3), 621–632. https://doi.org/10.1002/ijc.22527

Article  CAS  PubMed  Google Scholar 

Torre, L. A., Trabert, B., DeSantis, C. E., Miller, K. D., Samimi, G., Runowicz, C. D., … Siegel, R. L. (2018). Ovarian cancer statistics, 2018. CA: A Cancer Journal for Clinicians, 68(4), 284–296. https://doi.org/10.3322/caac.21456

Bowtell, D. D. L. (2010). The genesis and evolution of high-grade serous ovarian cancer. Nature Reviews Cancer, 10(11), 803–808. https://doi.org/10.1038/nrc2946

Article  CAS  PubMed  Google Scholar 

Siegel, R. L., Miller, K. D., & Jemal, A. (2018). Cancer statistics, 2018. CA: A Cancer Journal for Clinicians, 68(1), 7–30. https://doi.org/10.3322/caac.21442

Huang, J., Chan, W. C., Ngai, C. H., Lok, V., Zhang, L., Lucero-Prisno, D. E., … Wong, M. C. S. (2022). Worldwide burden, risk factors, and temporal trends of ovarian cancer: A global study. Cancers, 14(9), 2230. https://doi.org/10.3390/cancers14092230

Momenimovahed, Z., Tiznobaik, A., Taheri, S., & Salehiniya, H. (2019). Ovarian cancer in the world: Epidemiology and risk factors. International Journal of Women’s Health, 11, 287–299. https://doi.org/10.2147/IJWH.S197604

Article  PubMed  PubMed Central  Google Scholar 

Orr, B., & Edwards, R. P. (2018). Diagnosis and treatment of ovarian cancer. Hematology/Oncology Clinics of North America, 32(6), 943–964. https://doi.org/10.1016/j.hoc.2018.07.010

Article  PubMed  Google Scholar 

McCluggage, W. G., Singh, N., & Gilks, C. B. (2022). Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020). Histopathology, 80(5), 762–778. https://doi.org/10.1111/his.14609

Olawaiye, A. B., Cuello, M. A., & Rogers, L. J. (2021). Cancer of the vulva: 2021 update. International Journal of Gynecology & Obstetrics, 155(S1), 7–18. https://doi.org/10.1002/ijgo.13881

Article  Google Scholar 

Avril, N., Gourtsoyianni, S., & Reznek, R. (2011). Gynecological cancers (pp. 171–189). https://doi.org/10.1007/978-1-61779-062-1_10

Fader, A. N., & Rose, P. G. (2007). Role of surgery in ovarian carcinoma. Journal of Clinical Oncology, 25(20), 2873–2883. https://doi.org/10.1200/JCO.2007.11.0932

Article  PubMed  Google Scholar 

Chargari, C., Peignaux, K., Escande, A., Renard, S., Lafond, C., Petit, A., … Haie-Méder, C. (2022). Radiotherapy of cervical cancer. Cancer/Radiothérapie, 26(1–2), 298–308. https://doi.org/10.1016/j.canrad.2021.11.009

Bejar, F. G., Oaknin, A., Williamson, C., Mayadev, J., Peters, P. N., Secord, A. A., … Coffman, L. G. (2022). Novel therapies in gynecologic cancer. American Society of Clinical Oncology Educational Book, (42), 483–499. https://doi.org/10.1200/EDBK_351294

Pakish, J. B., & Jazaeri, A. A. (2017). Immunotherapy in gynecologic cancers: Are we there yet? Current Treatment Options in Oncology, 18(10), 59. https://doi.org/10.1007/s11864-017-0504-y

Article  PubMed  PubMed Central  Google Scholar 

Mitra, S., Lami, M. S., Ghosh, A., Das, R., Tallei, T. E., & Fatimawali, … Emran, T. Bin. (2022). Hormonal therapy for gynecological cancers: How far has science progressed toward clinical applications? Cancers, 14(3), 759. https://doi.org/10.3390/cancers14030759

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dochez, V., Caillon, H., Vaucel, E., Dimet, J., Winer, N., & Ducarme, G. (2019). Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review. Journal of Ovarian Research, 12(1), 28. https://doi.org/10.1186/s13048-019-0503-7

Article  PubMed  PubMed Central  Google Scholar 

Wu, L., Shang, W., Zhao, H., Rong, G., Zhang, Y., Xu, T., … Wang, F. (2019). In silico screening of circulating microRNAs as potential biomarkers for the diagnosis of ovarian cancer. Disease Markers, 2019, 1–12. https://doi.org/10.1155/2019/7541857

Penzo, M., Montanaro, L., Treré, D., & Derenzini, M. (2019). The ribosome biogenesis—Cancer connection. Cells, 8(1), 55. https://doi.org/10.3390/cells8010055

Article  CAS  PubMed  PubMed Central  Google Scholar 

Buttgereit, F., & Brand, M. D. (1995). A hierarchy of ATP-consuming processes in mammalian cells. Biochemical Journal, 312(1), 163–167. https://doi.org/10.1042/bj3120163

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nevins, T. A., Harder, Z. M., Korneluk, R. G., & Holčı́k, M. (2003). Distinct regulation of internal ribosome entry site-mediated translation following cellular stress is mediated by apoptotic fragments of eIF4G translation initiation factor family members eIF4GI and p97/DAP5/NAT1. Journal of Biological Chemistry, 278(6), 3572–3579. https://doi.org/10.1074/jbc.M206781200

Article  CAS  PubMed  Google Scholar 

Ramírez-Valle, F., Braunstein, S., Zavadil, J., Formenti, S. C., & Schneider, R. J. (2008). eIF4GI links nutrient sensing by mTOR to cell proliferation and inhibition of autophagy. The Journal of cell biology, 181(2), 293–307. https://doi.org/10.1083/jcb.200710215